FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084727 [Registered on: 15/04/2025] Trial Registered Prospectively
Last Modified On: 14/04/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   This is observational study to observe the effectiveness and safety of estradiol hemihydrate tablet. 
Study Design  Other 
Public Title of Study   This is a study to observe the effectiveness and safety of estradiol hemihydrate tablet usage vaginally in patients with thin endometrial for endometrial preparation in Frozen Embryo Transfer (FET) cycles 
Scientific Title of Study   A retrospective investigator-initiated study to observe the effectiveness and safety of estradiol hemihydrate tablet usage vaginally in patients with thin endometrial for endometrial preparation in Frozen Embryo Transfer (FET) cycles 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Protocol No: 0020-25, Version: 1.0, Dated: 10 Dec 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jatin Shah 
Designation  Principal Investigator 
Affiliation  Kamala Poly Clinic & Nursing Home 
Address  66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India

Mumbai
MAHARASHTRA
400025
India 
Phone  9820080449  
Fax  9820080449  
Email  drjatin2000@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jatin Shah 
Designation  Principal Investigator 
Affiliation  Kamala Poly Clinic & Nursing Home 
Address  66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India


MAHARASHTRA
400025
India 
Phone  9820080449  
Fax  9820080449  
Email  drjatin2000@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jatin Shah 
Designation  Principal Investigator 
Affiliation  Kamala Poly Clinic & Nursing Home 
Address  66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India


MAHARASHTRA
400025
India 
Phone  9820080449  
Fax  9820080449  
Email  drjatin2000@gmail.com  
 
Source of Monetary or Material Support  
Dr. Jatin Shah, Kamala Poly Clinic & Nursing Home, 66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India  
 
Primary Sponsor  
Name  Dr Jatin Shah 
Address  Kamala Poly Clinic & Nursing Home, 66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NA  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jatin Shah  Kamala Poly Clinic & Nursing Home  Department of Clinical Research, Room No. NA, 66-C, Motiwala Building, 1st Floor, A K Marg, West, Opposite Aung Kranti Maidan, Gowalia Tank, Grant Road, Mumbai, Maharashtra- 400025, India
Mumbai
MAHARASHTRA 
9820080449

drjatin2000@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Indira IVF Hospital Ethics Committee- Mumbai, Dr. Jatin Shah  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NA  NA 
Comparator Agent  NA  NA 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  42.00 Year(s)
Gender  Both 
Details  a. Age 25 to 42 years (both inclusive)
b. Patients planned to undergo Frozen embryo transfer cycle where endometrial preparation will be
done by hormone replacement therapy (HRT)
c. Normal pelvic ultrasonography 
 
ExclusionCriteria 
Details  a. Women who smoke
b. Women under 25 years or over 42 years of age
c. Women who had unexplained vaginal bleeding
d. Women who had Ashermans syndrome
e. Women with history of Malignancy, HIV and Tubercular endometritis
g. Any Contraindications for receiving estradiol
h. Hypersensitivity to estradiol or any of its excipients
i. Any other condition which precludes the use of estradiol 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
A retrospective real world observational study to observe the effectiveness and safety of estradiol
hemihydrate tablet usage vaginally in patients with thin endometrial for artificial endometrial
preparation in Frozen Embryo Transfer (FET) cycles 
Following retrospective data will be collected in this study.
• Patients Age
• Duration and cause of Infertility
• Number of previous IVF treatment cycle
• Base line investigations
• Endometrial thickness - before starting and after administration of vaginal estradiol
hemihydrate; and on progesterone start day
• Pregnancy test - positive or negative 10 to 15 days after embryo 
 
Secondary Outcome  
Outcome  TimePoints 
NA  NA 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a retrospective real world observational study to observe the effectiveness and safety of estradiol hemihydrate tablet usage vaginally in patients with thin endometrial for artificial endometrial preparation in Frozen Embryo Transfer (FET) cycles
 
Close